Evidence map›Paper›PMID 36432221›Full record

ArticleNanomaterials (Basel, Switzerland)2022

An In Vitro Dosimetry Tool for the Numerical Transport Modeling of Engineered Nanomaterials Powered by the Enalos RiskGONE Cloud Platform.

Nikolaos Cheimarios, Barbara Pem, Andreas Tsoumanis, Krunoslav Ilić, Ivana Vinković Vrček, Georgia Melagraki, Dimitrios Bitounis, Panagiotis Isigonis, Maria Dusinska, Iseult Lynch and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 7 countries.

Nikolaos CheimariosNovaMechanics Ltd., Nicosia 1070, Cyprus.ORCID 0000-0002-3073-0392
Barbara PemInstitute for Medical Research and Occupational Health, 10 000 Zagreb, Croatia.
Andreas TsoumanisNovaMechanics Ltd., Nicosia 1070, Cyprus.
Krunoslav IlićInstitute for Medical Research and Occupational Health, 10 000 Zagreb, Croatia.
Ivana Vinković VrčekInstitute for Medical Research and Occupational Health, 10 000 Zagreb, Croatia.ORCID 0000-0003-1382-5581
Georgia MelagrakiHellenic Military Academy, 16673 Vari, Greece.
Dimitrios BitounisCenter for Nanotechnology and Nanotoxicology, HSPH-NIEHS Nanosafety Research Center, Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA.
Panagiotis IsigonisDepartment of Environmental Sciences, Informatics and Statistics, Ca' Foscari University of Venice, 30172 Venice, Italy.ORCID 0000-0002-8404-7708
Maria DusinskaDepartment of Environmental Chemistry, Health Effects Laboratory, NILU-Norwegian Institute for Air Research, 2007 Kjeller, Norway.ORCID 0000-0003-1358-1652
Iseult LynchSchool of Geography, Earth and Environmental Sciences, University of Birmingham, Birmingham B15 2TT, UK.ORCID 0000-0003-4250-4584
Philip DemokritouCenter for Nanotechnology and Nanotoxicology, HSPH-NIEHS Nanosafety Research Center, Department of Environmental Health, Harvard School of Public Health, Boston, MA 02115, USA.ORCID 0000-0002-2484-9143
Antreas AfantitisNovaMechanics Ltd., Nicosia 1070, Cyprus.ORCID 0000-0002-0977-8180
Institute for Medical Research and Occupational Health · HRNovaMechanics (Cyprus) · CYNational Institute of Environmental Health Sciences · USCa' Foscari University of Venice · ITHellenic Military Academy · GRNILU · NOUniversity of Birmingham · GB

Funding

CompSafeNano project 101008099European Union's Horizon 2020 814425 - RiskGONE project
6 · The paper itself

Abstract

A freely available "in vitro dosimetry" web application is presented enabling users to predict the concentration of nanomaterials reaching the cell surface, and therefore available for attachment and internalization, from initial dispersion concentrations. The web application is based on the distorted grid (DG) model for the dispersion of engineered nanoparticles (NPs) in culture medium used for in vitro cellular experiments, in accordance with previously published protocols for cellular dosimetry determination. A series of in vitro experiments for six different NPs, with Ag and Au cores, are performed to demonstrate the convenience of the web application for calculation of exposure concentrations of NPs. Our results show that the exposure concentrations at the cell surface can be more than 30 times higher compared to the nominal or dispersed concentrations, depending on the NPs' properties and their behavior in the cell culture medium. Therefore, the importance of calculating the exposure concentration at the bottom of the cell culture wells used for in vitro arrays, i.e., the particle concentration at the cell surface, is clearly presented, and the tool introduced here allows users easy access to such calculations. Widespread application of this web tool will increase the reliability of subsequent toxicity data, allowing improved correlation of the real exposure concentration with the observed toxicity, enabling the hazard potentials of different NPs to be compared on a more robust basis.

Indexed as

Au and Ag nanoparticlesdistorted grid modelEnalos Cloud Platformin vitro dosimetrynanotoxicity

Identifiers

PMID36432221
PMCPMC9697428
OpenAlexW4308514113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.